Ep192: Kate Haviland on Following the Science to Precision Immunology
The Long Run with Luke Timmerman
00:00
Commercial Performance and Growth Metrics
Kate summarizes Avapritinib's strong uptake, patient adherence, new prescribers, and durable revenue trajectory.
Play episode from 01:15:28
Transcript
